GOLDMAN SACHS GROUP INC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 85 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$93,403
+96.0%
36,773
+44.3%
0.00%
Q4 2022$47,664
-76.2%
25,489
-67.2%
0.00%
Q3 2022$200,000
+13.0%
77,817
-15.4%
0.00%
Q2 2022$177,000
-77.1%
91,948
-64.6%
0.00%
Q1 2022$772,000
-32.4%
259,942
+2.2%
0.00%
Q4 2021$1,142,000
-13.7%
254,313
-6.7%
0.00%
Q3 2021$1,324,000
-23.8%
272,439
+7.0%
0.00%
Q2 2021$1,737,000
+0.6%
254,625
+4.2%
0.00%
Q1 2021$1,726,000
+11.4%
244,359
-1.3%
0.00%
Q4 2020$1,549,000
+83.1%
247,579
+58.3%
0.00%
Q3 2020$846,000
-28.3%
156,421
-30.8%
0.00%
Q2 2020$1,180,000
+73.3%
226,154
+4.6%
0.00%
Q1 2020$681,000
-50.5%
216,310
-36.6%
0.00%
Q4 2019$1,376,000
+140.6%
341,322
+157.5%
0.00%
Q3 2019$572,000
+262.0%
132,567
+233.7%
0.00%
Q2 2019$158,000
-56.0%
39,723
-40.7%
0.00%
Q1 2019$359,000
-14.7%
66,979
-18.5%
0.00%
Q4 2018$421,000
+10.5%
82,171
+109.4%
0.00%
Q3 2018$381,000
-77.3%
39,241
-76.1%
0.00%
Q2 2018$1,675,000
+154.2%
164,178
+224.0%
0.00%
Q1 2018$659,000
-22.2%
50,673
+7.1%
0.00%
Q4 2017$847,000
-83.2%
47,328
-76.4%
0.00%
-100.0%
Q3 2017$5,030,000
+58.4%
200,371
+52.1%
0.00%0.0%
Q2 2017$3,175,000
+76.4%
131,723
+40.9%
0.00%
Q1 2017$1,800,000
+46.8%
93,501
+17.5%
0.00%
Q4 2016$1,226,000
-14.6%
79,595
-27.8%
0.00%
Q3 2016$1,435,000
+13.0%
110,227
+20.7%
0.00%
Q2 2016$1,270,000
+247.9%
91,334
+682.0%
0.00%
Q1 2015$365,00011,6790.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders